Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-14

Clinical Trial Update: Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing therapeutic equivalence of 5% fluorouracil cream vs 5% topical cream for actinic keratosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluorouracil 5% Topical Cream (fluorouracil)
  • Fluorouracil Cream, 5% (fluorouracil)

Snippet

Sponsor: Encube Ethicals Pvt. Ltd. | Conditions: Actinic Keratoses | Phase 3 | Status: COMPLETED